What is Vascular Flow Technologies?
Vascular Flow Technologies is an ISO 13485 certified entity focused on the pre-clinical development, testing, and contract manufacturing of cardiovascular devices. Leveraging its proprietary Spiral Laminar Flow Technology, the company aims to optimize blood flow dynamics within vascular implants, thereby enhancing patient outcomes. Vascular Flow Technologies collaborates with a diverse range of partners, including medical device firms, academic institutions, inventors, and small to medium-sized enterprises (SMEs), offering bespoke services to accelerate the journey from initial concept to market commercialization. Their integrated approach encompasses research, development, rigorous testing, and regulatory guidance, ensuring a streamlined path for new medical devices.
How much funding has Vascular Flow Technologies raised?
Vascular Flow Technologies has raised a total of $14.3M across 2 funding rounds:
Series A
$10M
Series B
$4.3M
Series A (2016): $10M, investors not publicly disclosed
Series B (2016): $4.3M, investors not publicly disclosed
What's next for Vascular Flow Technologies?
The substantial enterprise-level funding indicates a pivotal growth phase for Vascular Flow Technologies. This capital infusion is expected to fuel further research and development, potentially expanding the application of their Spiral Laminar Flow Technology to a broader range of cardiovascular conditions. The company is well-positioned to scale its operations, enhance its contract manufacturing capabilities, and solidify its partnerships within the medical device ecosystem. Future strategic initiatives will likely focus on clinical validation and market penetration, capitalizing on the recent investment to drive innovation and improve patient care in vascular health.
See full Vascular Flow Technologies company page
